The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2022

Filed:

Jan. 15, 2018
Applicant:

Leukos Biotech, S.l., Barcelona, ES;

Inventors:

Ruth Muñoz Risueño, Barcelona, ES;

Mari Carmen Lara Castillo, Barcelona, ES;

Amaia Etxabe Alberdi, Barcelona, ES;

Assignee:

Leukos Biotech, S.L., Barcelona, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/7068 (2006.01); A61P 35/02 (2006.01); A61K 31/485 (2006.01); A61K 31/55 (2006.01); A61K 31/706 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7068 (2013.01); A61K 31/485 (2013.01); A61K 31/55 (2013.01); A61K 31/706 (2013.01); A61P 35/02 (2018.01);
Abstract

The invention relates to a combination comprising an antineoplastic agent, e.g. an antimetabolite antineoplastic agent and a type 1 serotonin receptor (HTR1) modulator, e.g. a HTR1 antagonist. In addition the invention relates to a pharmaceutical composition comprising a combination of the invention and a pharmaceutically acceptable excipient. The invention also relates to the combination and pharmaceutical composition according to the invention for use in medicine, particularly for use in the prevention and/or treatment of a hematological malignancy.


Find Patent Forward Citations

Loading…